AZD3427, a novel relaxin receptor agonist and impact on renal perfusion in patients with heart failure with reduced ejection rraction: the phase 1b Re-Perfuse study design
18 May 2025 (10:36 - 12:12)
Organised by: 
About the speaker
Medical University of Warsaw, Warsaw (Poland)
4 More presentations in this session
Associate Professor I. Colluoglu (Izmir, TR)
Doctor L. Mikic (Belgrade, RS)
Access the full session
The Event
Heart Failure 2025
18 May 2025
10:36 CET
You may be interested in
Congress Session
